Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arthritis Patients

SDF-1 signaling: a promising target in rheumatic diseases

(2014) Amanda Villalvilla et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

MRI comes of age in RA clinical trials

(2013) Charles Peterfy et al.   ANNALS OF THE RHEUMATIC DISEASES

Genetics of rheumatoid arthritis contributes to biology and drug discovery

(2013) Yukinori Okada et al.   NATURE

Comparison of OMERACT-RAMRIS scores and computer-aided dynamic magnetic resonance imaging findings of hand and wrist as a measure of activity in rheumatoid arthritis

(2013) Sebnem Orguc et al.   RHEUMATOLOGY INTERNATIONAL

Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells

(2012) K. A. Oduro et al.   BLOOD

Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients

(2012) L. R. Coulthard et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Platelets: active players in the pathogenesis of arthritis and SLE

(2012) Eric Boilard et al.   Nature Reviews Rheumatology

Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis

(2012) MB Axelsen et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

(2012) Dirk Koczan et al.   ARTHRITIS RESEARCH & THERAPY

American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010

(2011)   ARTHRITIS AND RHEUMATISM

Genetic and genomic predictors of anti-TNF response

(2011) Rita Prajapati et al.   PHARMACOGENOMICS

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis

(2011) K. Van Steendam et al.   RHEUMATOLOGY

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

(2010) Lisa GM van Baarsen et al.   ARTHRITIS RESEARCH & THERAPY

Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells

(2009) Motohiko Tanino et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients With Rheumatoid Arthritis

(2009) B Stuhlmüller et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Convergent random forest predictor: Methodology for predicting drug response from genome-scale data applied to anti-TNF response

(2009) Jadwiga R. Bienkowska et al.   GENOMICS

Phase 2 Trial of Recombinant Tumor Necrosis Factor-α in Combination With Dactinomycin in Children With Recurrent Wilms Tumor

(2009) Holly J. Meany et al.   JOURNAL OF IMMUNOTHERAPY

An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis

(2009) Antonio Julià et al.   PLoS One

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

(2008) C Trocme et al.   ANNALS OF THE RHEUMATIC DISEASES

A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus

(2008) Damien Chaussabel et al.   IMMUNITY

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-α monoclonal antibody, infliximab

(2008) N. Sekiguchi et al.   RHEUMATOLOGY

MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy

(2007) R. J. Hodgson et al.   RHEUMATOLOGY